Buyer guide

How to Make Bioinformatics Analyses Reproducible and Publication-Ready

True publication-ready bioinformatics means anyone—from a colleague to a peer reviewer—can seamlessly rerun your analysis from the same inputs. However, achieving this standard is notoriously difficult in practice. In fact, one study found that only 5.6% of biomedical Jupyter notebooks with declared dependencies produced identical results upon rerun [1]. To help you beat these odds, this guide provides a publication-readiness checklist, highlights common mistakes to avoid, and outlines actionable steps for your project—whether the analysis runs in-house, at a core, or through a CRO.

Key facts

Key facts about Reproducibility in Bioinformatics
FactDetailSource
Microarray analysis reproducibilityOnly 2 of 18 published microarray analyses reproduced in principle; 10 could not be reproduced at all[2]
Notebook re-execution success5.6% of biomedical Jupyter notebooks with declared dependencies produced identical results on automated rerun (879 of 15,817)[1]
Researcher reproduction experience>70% of 1,576 surveyed researchers tried and failed to reproduce another scientist's experiment[3]
NIH intramural reproduction attempts0 of 5 bioinformatics papers were fully reproduced in an NLM workshop; missing data, software, and documentation cited[4, 5]
NGS Methods documentation gapFewer than half of 50 NGS papers provided any software-version or parameter details (via Nekrutenko & Taylor, 2012, cited in Piccolo & Frampton, 2016)[6]
Spreadsheet gene-list errors30.9% of PubMed Central articles with supplementary Excel gene lists contain gene-name conversion errors (3,436 of 11,117)[7]
Funder reproducibility expectationsNIH DMS Policy effective 25 January 2023; DMSP must address related tools, software, and code; Wellcome requires data and software needed to replicate analyses at publication minimum[8, 9]

What Is the Reproducibility Crisis in Bioinformatics?

The reproducibility crisis in bioinformatics is the gap between published claims and what an independent analyst can actually rerun from available data, code, and documentation. In computational work, reproducibility usually means obtaining consistent results from the same data and pipeline; replicability means obtaining consistent results from new data under the same protocol [10]. Published bioinformatics can fail both tests more often than many labs expect.

Ioannidis et al. [2], Zaringhalam & Federer [4], and Samuel & Mietchen [1] document the same pattern: missing data, versions, and documentation—not biology—block rerun. Software defaults, reference builds, and unlogged manual steps can change results silently across years.

What Should a Publication-Ready Reproducibility Checklist Include?

A publication-ready analysis covers five deliverable areas—data, software, documentation, scripts, and delivery—so a second analyst can rerun every figure without guessing [5, 11]. Use this table at project kickoff and as acceptance criteria before final payment or manuscript submission.

Five-pillar reproducibility checklist for publication-ready bioinformatics
PillarMinimum requirement
DataRaw FASTQ/BAM archived; metadata in CSV/TSV linked by sample ID; accession IDs in DMSP [8]
SoftwareVersion-pinned environment (`environment.yml`, `requirements.txt`, or `renv.lock`); reference build named
DocumentationNon-default parameters and random seeds logged [11]
ScriptsVersion-controlled analysis scripts with step-by-step documentation; avoid irreversible Excel steps for gene lists [7]
DeliveryGit repo + README with documented rerun steps; environment file validated on a machine your lab controls

Who enforces these standards?

Who enforces reproducibility standards in bioinformatics workflows
ApproachReproducibility enforcementBest when
In-house with SOPsYou own standards; quality often depends on practice and turnoverContinuous pipeline work across grants
Academic core facilitySOPs and documentation depth vary with staff and queue pressureStandard assays with predictable local pricing
External bioinformatics CRODeliverables can be specified—environment files, Git handoff, milestone criteriaOne-off projects, specialist modalities, tight deadlines
Sequencing vendor bundleOften QC-focused; parameter logs and code may be limitedInternal QC—not final manuscript analysis

Outsourcing does not guarantee reproducibility. Black-box PDF reports without code remain a common failure mode. If you outsource, specify deliverables in the statement of work—the bioinformatics CRO guide covers vendor due diligence; this page covers what those deliverables should contain.

What Are the Most Common Mistakes?

Most reproducibility failures are preventable process errors discovered at peer review or when extending an analysis years later.

  1. 1. Confusing code sharing with re-execution

    Cadwallader et al. [12] report 87% code-sharing at PLOS Computational Biology for post-policy submissions—but Samuel & Mietchen [1] found only 5.6% of notebooks with declared dependencies reproduced identical results.

  2. 2. Using Excel for gene lists

    Ziemann et al. [7] found errors in 30.9% of supplementary Excel gene lists [13].

  3. 3. Documenting tool names but not versions

    Piccolo & Frampton [6] cite Nekrutenko & Taylor (2012): fewer than half of 50 NGS papers provided any software-version or parameter details.

  4. 4. Treating reproducibility as post-hoc

    Version-pinning and script documentation belong at study design, not the week before submission.

  5. 5. Assuming bundled analysis is manuscript-ready

    Many NGS workflows lack version and parameter detail needed for independent rerun [6].

  6. 6. Skipping a pilot re-run

    Test one figure on a clean machine before processing a full cohort [5, 11].

What Can You Do in the Next Two Weeks?

  • Add reproducibility acceptance criteria to your next SOW or RFP: version-locked environment (`environment.yml` or `requirements.txt`), Git repo, parameter log, and draft Methods—not a PDF alone.
  • Align your DMSP or outputs management plan with actual deliverables before sequencing [8, 9].
  • State reference builds (GRCh38 vs GRCh37) and random seeds in study design documents.
  • Budget repository fees, compute, and re-execution as justified direct costs where your funder allows [8].

How Do Funder and Journal Requirements Affect Your Workflow?

NIH requires sharing scientific data needed to validate findings and a DMSP section on related tools, software, and code (effective 25 January 2023) [8]. Code sharing is encouraged but not always mandated for public release.

Wellcome requires an outputs management plan; as a minimum, data underpinning papers and software required to view datasets or replicate analyses should be available at publication [9]. UKRI expects open data where possible with reuse documentation [14].

Nature Portfolio requires custom code central to claims on request and a Code Availability statement at publication; Zenodo or Code Ocean deposition is considered best practice [15].

What to Do Next

  • Audit your most recent omics project against the five-pillar checklist above; list every gap.
  • Add reproducibility acceptance criteria to your next statement of work or internal analysis plan.
  • Read the bioinformatics CRO guide if you plan to outsource any part of the pipeline.
  • Read the bioinformatics cost guide to budget for environment setup, repository fees, and reviewer support.
  • If you want help scoping reproducibility deliverables before sequencing, you may request a consultation with Pepkio, your institutional core, or another qualified provider.

Frequently asked questions

What is reproducibility in bioinformatics?

Reproducibility in bioinformatics means an independent analyst can obtain consistent results from the same data using the documented scripts, software versions, and parameters. It requires archived raw data, version-pinned software, documented analysis scripts, and logged non-default settings [5, 11]. It is distinct from replicability, which tests whether findings hold in new data collected under the same protocol.

Why is bioinformatics harder to reproduce than wet-lab experiments?

Computational results depend on software versions, reference genome builds, random seeds, and parameter choices that are easy to change and hard to notice. Samuel & Mietchen [1] found that only 879 of 15,817 biomedical notebooks with declared dependencies produced identical results on automated rerun; most other attempts failed with runtime exceptions. A wet-lab protocol can be written in a few pages; a transcriptomics pipeline may involve dozens of tools with version-sensitive defaults.

What should be in a reproducible bioinformatics deliverable?

At minimum: raw and processed data files, version-controlled scripts with step-by-step documentation, a version-locked environment (`environment.yml` or `requirements.txt`), a parameter log, figure-generation code tied to stored outputs, and a README with rerun instructions [11]. Specify reference genome builds and random seeds. A PDF report or Excel gene list alone does not qualify.

Do I need to share raw sequencing data to be reproducible?

You must retain data sufficient to validate findings—often raw reads plus metadata. Public deposition depends on funder policy, journal requirements, and participant consent [8, 9]. Controlled-access repositories satisfy many human-subject requirements; reviewers may need timely access under embargo when public release is delayed.

What is the difference between reproducibility and replicability?

Reproducibility means rerunning the same analysis on the same data and getting consistent results. Replicability means collecting new data under the same experimental design and obtaining consistent biological conclusions. Ioannidis et al. [2] tested reproducibility of published computational analyses; both concepts matter, but bioinformatics projects most often fail at the reproducibility step first.

Is the reproducibility crisis exaggerated?

The label is debated, but the failure rates are not. Baker [3] found more than 70% of surveyed researchers had tried and failed to reproduce another scientist's experiment. Ioannidis et al. [2] and Zaringhalam & Federer [4] document specific bioinformatics failures. Whether you call it a "crisis" or a "gap," the practical risk for your lab is the same: unpublished or contested work when documentation is thin.

Will a pinned environment file alone make my analysis reproducible?

No. A conda or venv lock file captures software versions but not undocumented manual steps, missing data, unstated parameters, or wrong random seeds [11]. Version-pinned environments address compute-environment control in reproducibility frameworks [5]—not a substitute for documented scripts, version control, and complete metadata.

Do journals actually verify that code runs?

Policies vary by journal. Nature Portfolio requires code central to claims on request and a Code Availability statement at publication [15]. Cadwallader et al. [12] raised sharing rates at PLOS Computational Biology after a mandatory policy; Samuel & Mietchen [1] show shared notebooks often still fail on re-execution. Assume reviewers may attempt to run your code.

Can I meet NIH requirements without publishing code publicly?

Often yes. NIH requires data sharing for validation and replication; code sharing is encouraged but not universally mandated for public release [8]. Your DMSP must still describe related tools, software, and code access. Many labs share code on request, via controlled repositories, or under embargo. You must have runnable artifacts—not necessarily a public GitHub repo on day one.

How do I verify a CRO's reproducibility claims before signing?

Request a redacted reproducibility package from a completed project: `environment.yml` or `requirements.txt`, Git repository, documented scripts, and parameter log. Run a paid pilot on a subset of your data before committing to the full cohort. Apply the checklist on this page as milestone acceptance criteria. The bioinformatics CRO guide lists additional vendor questions.

Related resources

References
  1. Samuel, S., & Mietchen, D. (2024). Computational reproducibility of Jupyter notebooks from biomedical publications. GigaScience, 13, giad113. https://doi.org/10.1093/gigascience/giad113
  2. Ioannidis, J. P. A., Allison, D. B., Ball, C. A., et al. (2009). Repeatability of published microarray gene expression analyses. Nature Genetics, 41(2), 149–155. https://doi.org/10.1038/ng.295
  3. Baker, M. (2016). 1,500 scientists lift the lid on reproducibility. Nature, 533(7604), 452–454. https://doi.org/10.1038/533452a
  4. Zaringhalam, M., & Federer, L. (2020). Data and code for reproducible research: Lessons learned from the NLM reproducibility workshop. Zenodo. https://doi.org/10.5281/zenodo.3818329
  5. Ziemann, M., Poulain, P., & Bora, A. (2023). The five pillars of computational reproducibility: bioinformatics and beyond. Briefings in Bioinformatics, 24(6), bbad375. https://doi.org/10.1093/bib/bbad375
  6. Piccolo, S. R., & Frampton, M. B. (2016). Tools and techniques for computational reproducibility. GigaScience, 5, 30. https://doi.org/10.1186/s13742-016-0135-4
  7. Ziemann, M., Kaspi, A., & El-Osta, A. (2021). Gene name errors: lessons not learned. PLOS Computational Biology, 17(7), e1008984. https://doi.org/10.1371/journal.pcbi.1008984
  8. National Institutes of Health. (2023). NIH policy for data management and sharing. https://grants.nih.gov/policy-and-compliance/policy-topics/sharing-policies/dms/policy-overview
  9. Wellcome Trust. (n.d.). Data, software and materials management and sharing policy. https://wellcome.org/research-funding/guidance/policies-grant-conditions/data-software-materials-management-and-sharing-policy
  10. National Academies of Sciences, Engineering, and Medicine. (2019). Reproducibility and Replicability in Science. National Academies Press. https://doi.org/10.17226/25303
  11. Sandve, G. K., Nekrutenko, A., Taylor, J., & Hovig, E. (2013). Ten simple rules for reproducible computational research. PLOS Computational Biology, 9(10), e1003285. https://doi.org/10.1371/journal.pcbi.1003285
  12. Cadwallader, L., Mac Gabhann, F., Papin, J., & Pitzer, V. E. (2022). Advancing code sharing in the computational biology community. PLOS Computational Biology, 18(6), e1010193. https://doi.org/10.1371/journal.pcbi.1010193
  13. Zeeberg, B. R., Riss, J., Kane, D. W., et al. (2004). Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics. BMC Bioinformatics, 5, 80. https://doi.org/10.1186/1471-2105-5-80
  14. UK Research and Innovation. (2025). Making your research data open. https://www.ukri.org/manage-your-award/publishing-your-research-findings/making-your-research-data-open/
  15. Nature Portfolio. (n.d.). Reporting standards and availability of data, materials, code and protocols. https://www.nature.com/nature-portfolio/editorial-policies/reporting-standards

Let's Talk About Your Science

Tell us:

  • • Your biological question
  • • Data type and size
  • • Timeline constraints

We'll tell you:

  • • What's feasible
  • • How long it will take
  • • Exactly what it will cost
Contact Us

Contact us to start with a free consultation. Need everyday bench calculators? Try our free lab tools.